ARID1A depletion accelerates epithelial-mesenchymal transition, increases cancer stemness and promotes migration, invasion and angiogenesis in various cancers, including breast cancer, uterus cancer and pancreatic cancer by reducing the chromatin accessibility of target genes or influencing the post-transcriptional modification process (Wilson et al., 2019; Luo et al., 2020; Wang et al., 2020; Tomihara et al., 2021). The gene discussed is ARID1A; the disease is uterine cancer.